For example, inhibition of the action of tumour necrosis factor (TNF) [3, 4] or granulocyte macrophage-colony stimulating factor (GM-CSF) [5] ameliorates joint pain in animal models of inflammatory arthritis and also clinically in RA patients [6, 7]. The gene discussed is CSF2; the disease is rheumatoid arthritis.